Author:
CASS L.M.R.,GUNAWARDENA K.A.,MACMAHON M.M.,BYE A.
Subject
Pulmonary and Respiratory Medicine
Reference17 articles.
1. Rational design of potent sialidase based inhibitors of influenza virus replication;Von Itzstein;Nature,1993
2. 4-Guanidino-2,4-dideoxy-2,3-dehydro-N-acetylneuraminic acid is a highly effective inhibitor both of the sialadase (neuraminidase) and of growth of a wide range of influenza A and B viruses in vitro;Woods;Antimicrob Agents Chemother,1993
3. Inhibition of influenza virus replication in mice by GG167 is consistent with extracellular activity of viral neuraminidase (sialidase);Ryan;Antimicrob Agents Chemother,1994
4. GG167 (4-guanidino-2,4-dideoxy-2,3-dehydro-n-acetylneuraminic acid) is a potent inhibitor of influenza virus in ferrets;Ryan;Antimicrob Agents Chemother,1995
5. Preclinical development of low toxicity drugs; Focus on zanamivir, an anti-influenza drug;Dines;Drug Safety,1998
Cited by
46 articles.
订阅此论文施引文献
订阅此论文施引文献,注册后可以免费订阅5篇论文的施引文献,订阅后可以查看论文全部施引文献
1. Antiviral Agents;Principles and Practice of Pediatric Infectious Diseases;2023
2. Use of antiviral drugs for seasonal influenza: Foundation document for practitioners—Update 2019;Official Journal of the Association of Medical Microbiology and Infectious Disease Canada;2019-06
3. Influenza burden, prevention, and treatment in asthma‐A scoping review by the
EAACI
Influenza in asthma task force;Allergy;2018-01-26
4. Antiviral Agents;Principles and Practice of Pediatric Infectious Diseases;2018
5. Antiviral Drugs in Newborn and Children;Pediatric Clinics of North America;2017-12